CLINICAL_TRIALS
withdrawal
· 2013-07-18
Clinical Trial Update: Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension [Phase 3]
Summary
A Phase 3 trial evaluating the safety and efficacy of a triple combination dorzolamide hydrochloride/brimonidine tartrate/timolol ophthalmic solution for glauco…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Glaucoma, Ocular Hypertension | Phase 3 | Status: WITHDRAWN